ATE174602T1 - Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle - Google Patents

Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle

Info

Publication number
ATE174602T1
ATE174602T1 AT93924266T AT93924266T ATE174602T1 AT E174602 T1 ATE174602 T1 AT E174602T1 AT 93924266 T AT93924266 T AT 93924266T AT 93924266 T AT93924266 T AT 93924266T AT E174602 T1 ATE174602 T1 AT E174602T1
Authority
AT
Austria
Prior art keywords
crystals
pct
growth hormone
date
alkyl
Prior art date
Application number
AT93924266T
Other languages
English (en)
Inventor
Ebba Florin-Robertsson
Elvy Hoekby
Ronny Lundin
Sirkka Thome
Gertrud Westin-Sjoedahl
Tomas Lundqvist
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/xx
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE174602T1 publication Critical patent/ATE174602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93924266T 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle ATE174602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone

Publications (1)

Publication Number Publication Date
ATE174602T1 true ATE174602T1 (de) 1999-01-15

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93924266T ATE174602T1 (de) 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle

Country Status (13)

Country Link
US (1) US5734026A (de)
EP (1) EP0669934B1 (de)
JP (1) JP3470135B2 (de)
AT (1) ATE174602T1 (de)
AU (1) AU679012B2 (de)
CA (1) CA2147482C (de)
DE (1) DE69322654T2 (de)
DK (1) DK0669934T3 (de)
ES (1) ES2126660T3 (de)
FI (1) FI110609B (de)
NO (1) NO320171B1 (de)
SE (1) SE9302278D0 (de)
WO (1) WO1994010192A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ATE397013T1 (de) 1997-09-05 2008-06-15 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6380357B2 (en) 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
CN1332711C (zh) * 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp－1分子的方法
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
DK1581251T3 (da) 2002-12-31 2016-06-27 Althea Tech Inc Krystaller af humant væksthormon og fremgangsmåder til fremstilling deraf
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203319A (es) * 1990-06-04 1992-07-31 Schering Corp Metodo para la preparacion de cristales de alfa-2 interferona.
DE69122517T2 (de) * 1990-06-15 1997-02-13 Schering Corp Kristallines interleukin-4
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
HK1013299A1 (en) 1999-08-20
US5734026A (en) 1998-03-31
JP3470135B2 (ja) 2003-11-25
DK0669934T3 (da) 1999-08-23
CA2147482C (en) 2003-09-23
SE9302278D0 (sv) 1993-07-02
NO320171B1 (no) 2005-11-07
CA2147482A1 (en) 1994-05-11
NO951547L (no) 1995-04-24
DE69322654T2 (de) 1999-06-17
WO1994010192A1 (en) 1994-05-11
EP0669934A1 (de) 1995-09-06
EP0669934B1 (de) 1998-12-16
FI952021L (fi) 1995-04-27
AU5401194A (en) 1994-05-24
DE69322654D1 (de) 1999-01-28
JPH08505127A (ja) 1996-06-04
NO951547D0 (no) 1995-04-24
AU679012B2 (en) 1997-06-19
FI110609B (fi) 2003-02-28
ES2126660T3 (es) 1999-04-01
FI952021A0 (fi) 1995-04-27

Similar Documents

Publication Publication Date Title
ATE174602T1 (de) Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
KR860002958A (ko) 살균제의 제법
DE69722027D1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
ATE168662T1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
ATE194601T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
ATE163418T1 (de) Risperidon pamoate
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
ATE154494T1 (de) Verfahren zur herstellung von käse
DE69104365D1 (de) Vaterit und verfahren zu dessen herstellung.
ATE205868T1 (de) Monofilmmembran, verfahren zu ihrer herstellung und ihre verwendung
ATE43344T1 (de) Neue 1-hydroxy-1,1-diphosphonsaeureverbindungen, verf. zu ihrer herstellung u. pharmakologische zubereitungen, insb. zur behandlung von knochentumoren.
ATE154023T1 (de) Phosphorsäureester und ihre verwendung zur herstellung biokompatibler oberflächen
DE3675016D1 (de) Verfahren zur fluoreszenzverbesserung von ti:al2o3 laserkristallen durch kontrolle von kristallzuechtung-atmosphaeren.
DE69614841D1 (de) Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
DE50201297D1 (de) Verfahren zur herstellung von 1-hydroxy-1, 1-diphosphonsäureverbindungen
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
DE69613101D1 (de) Verfahren zur herstellung von palatinitol
ATE169912T1 (de) Verfahren zur herstellung von 5-amino-1,3- dioxanen
ATE173259T1 (de) Verfahren zur herstellung von indolizinderivaten
DE69311736D1 (de) Verfahren zur herstellung einer 1,3-oxazolidin-5-carbonsäure
ATE309226T1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
DE3674122D1 (de) Verfahren zur herstellung optisch aktiver alpha-haloalkylarylketone.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee